Depo-Provera (depot medroxyprogesterone acetate, often shortened to DMPA) has been used for decades as an injectable form of birth control. For many patients, it’s been prescribed for convenience and reliability. In 2026, however, Depo-Provera is also at the center of rapidly evolving product-liability litigation focused on allegations that repeated/long-term use…
Updated: